A Non-Stochastic Quadratic Fingerprints-based approach is introduced to classify and design, in a rational way, new antitrypanosomal compounds. A data set of 153 organic-chemicals; 62 with antitrypanosomal activity and 91 having other clinical uses, was processed by a k-means cluster analysis in order to design training and predicting data sets. Afterwards, a linear classification function was derived allowing the discrimination between active and inactive compounds. The model classifies correctly more than 93% of chemicals in both training and external prediction groups. The predictability of this discriminant function was also assessed by a leave-group-out experiment, in which 10% of the compounds were removed at random at each time and their activity a posteriori predicted. Also a comparison with models generated using four well-known families of 2D molecular descriptors was carried out. As an experiment of virtual lead generation, the present TOMOCOMD approach was finally satisfactorily applied on the virtual evaluation of ten already synthesized compounds. The in vitro antitrypanosomal activity of this series against epimastigotes forms of T. cruzi was assayed. The model was able to predict correctly the behaviour of these compounds in 90% of the cases.
Introduction
Once an almost exclusively rural disease in Latin America, Chagas' disease, is now undergoing a change in its epidemiological profile due to rising levels of urbanization and migration. Latest data from de WHO indicates that over 24 million peoples are infected or at least serologically positive for Trypanosoma cruzi, which is the causative agent of such infection. This quantity roughly represents 8% of the total Latin America population. Another factor, blood transfusion is considered the second most frequent route of transmission in endemic countries, given parasites may survive in whole blood stored for more than 21 days at 4º C and detection techniques are not always strictly applied. 1 Medication for Chagas' disease is usually effective when it is given during the acute stage of infection. No medication has been proven to be effective once the disease has progressed to later stages. Moreover, synthetic drugs such as nifurtimox and benznidazole have severe side effects, including cardiac and/or renal toxicity. This explains the need for discovering new effective chemotherapeutic and chemoprophylactic agents against T. cruzi. 2, 3 In this sense, medicinal chemists are called to find new effective drugs in a fast and non-expensive way. In the last decades computer-aided drug design approaches have emerged as promising tools to be used to solve this problematic. [4] [5] [6] [7] [8] [9] [10] With the use of such design strategies it is possible the handling and screening of large databases in order to find reduced sets of potential new drug candidates. 11, 12 Thus, the development of computational approaches based on discrimination functions plays an important role, allowing the identification from large chemical libraries of structural subsystems responsible for a property or biological activity, and in this way, the classification of active compounds from inactive ones.
In this context, our research group has recently developed a novel scheme to generate molecular fingerprints based on the application of discrete mathematics and linear algebra theory, which permits to perform rational in silico molecular design (selection/identification) and QSAR/QSPR studies. Known as TOMOCOMD (acronym of TOpological MOlecular
COMputer Design), [13] [14] [15] [16] this approach has been successfully applied to the prediction of several physical, physicochemical, chemical, pharmacokinetical as well as biological properties. [17] [18] [19] It was, for instance, successfully used on the virtual screening of novel antihelminthic compounds, which were then synthesized and in vivo evaluated on Fasciola hepatica. 20, 21 Other studies for the rational discovery of novel paramphistomicides, 22 antimalarial 23 and antibacterial 24 compounds were also conducted with the TOMOCOMD approach. This method has been extended to consider three-dimensional features of small/medium-sized molecules upon the base of the application of a trigonometric 3D-chirality correction factor. 25 In the present study, TOMOCOMD strategy is used to find a classification model which allows discriminating antitrypanosomal compounds from inactive ones. It is also an objective of the present work to assess the model robustness and predictive power by using external and 
Results and Discussion
Computing Non-Stochastic Quadratic Molecular Fingerprints. In order to obtain quantitative structure-property or structure-activity relationships (abbreviated QSPR and QSAR, respectively), it is necessary to "convert" the molecular structures into numbers that could be later statistically processed; it means, a structural parameterization is required. By means of the computation of molecular descriptors, such problematic is overcome. 26 In the last decades a great number of molecular fingerprints have been presented in the literature. 27, 28 Atomic, atom-type and total non-stochastic quadratic indices have shown a great ability to encode chemical information, which can be used for the development of QSARs. The theoretical scaffold of this TOMOCOMD's molecular fingerprints has been presented in details in previous papers. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Here just a short overview will be given.
Atomic, atom-type and total molecular quadratic molecular indices have been defined in analogy to the quadratic mathematical maps. 14, 16 After constructing the molecular pseudograph's atom adjacency matrix M(G) and the molecular vector (X), whose components x 1 ,…,x n are numeric values or weights (atom-labels or atom-properties) for the vertices of the pseudograph, k th total quadratic indices, q k (x), can be computed for a given molecule composed of n atoms as shown in Eq. 1,
where, k a ij are the elements of the k th power of the symmetrical square matrix M(G) of the molecular pseudograph (G), and are defined as follows:
= L ii if i = j = 0 otherwise E(G) represents the set of edges (bonds) of G. P ij is the number of edges between vertices (atoms) v i and v j , and L ii is the number of loops in v i .
Equation (1) for q k (x) can also be written as a single matrix equation:
where X is a column vector (a nx1 matrix), X t the transpose of X (a 1xn matrix) and M k the k th power of the matrix M of the molecular pseudograph G.
In a similar way, local-fragment (atomic and atom-type) formalisms can be developed. The These local analogues can also be expressed in matrix form by the expression:
For every partition of a molecule into Z molecular fragment there will be Z local molecular fragment matrices M k L . The k th power of matrix M is exactly the sum of the k th power of the local Z matrices and in this way, the total quadratic indices are the sum of the quadratic indices of the Z molecular fragments: Training and test sets design. In order to obtain mathematical expressions capable of discriminating between active and inactive compounds, the chemical information contained in a great number of compounds with and without the desired biological activity must be statistically processed. Taking into account that the most critical aspect on the construction of a training data set is the molecular diversity of the included compounds, we selected a group of 153 organic chemicals having as much structural variability as possible. The antitrypanosomals considered on this study are representatives of families with diverse structural patterns. [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Figure 2 shows the whole active set collected from the literature for this work. The selected inactive group included antivirals, sedative/hypnotics, diuretics, anticonvulsivants, hemostatics, oral hypoglycemics, antihypertensives, antihelminthics, anticancer compounds as well as some other kinds of drugs, guaranteeing at the same time a great structural variability. 39 In order to split the whole group into two data sets (training and predicting ones), two k- In this sense, it can be concluded that the data set of antitrypanosomal compounds considered for this study encloses compounds of six general structural patterns codified by TOMOCOMD descriptors and recognized by a k-means cluster analysis.
Developing a Discriminant Function. Linear discriminant analysis (LDA) has become an important tool for the prediction of chemicals properties. On the basis of the simplicity of this method many useful discriminant models have been developed and presented by different authors in the literature. [7] [8] [9] [10] Being the election technique used on the generation of the TOMOCOMD approaches reported to date, [20] [21] [22] [23] [24] LDA was also employed in the current work to generate a discriminant function. The principle of parsimony (Occam's razor) was taken into account as strategy for model selection. 42 It means, that we select the model with higher statistical signification but having as few parameters (a k ) as possible. Table 2 shows these results. As can be computed from the results showed in Table 2 , model 8 classified correctly 93.02%
of the whole training data set (accuracy). This model showed a high Matthews´ correlation coefficient (MCC) of 0.87. MCC is a measure that may provide a much more balanced evaluation of the prediction than the percentages of good classification, because it uses all four numbers (true positive, true negative, false positive and false negatives). 44 Also the probability of correctly predicting a positive example (sensitivity or hit rate) and the probability that a positive prediction will be correct (specificity) were computed for the model. In both cases 92.31% was the obtained value. While these two later measures bring some information of the predictivity for positive observations, the negative predictive value (sensitivity of the negative category) gives a criterion of good classification for the inactive group. In this case a 95.08% was observed. 44 These results, as well as the "false positive rate" (false alarm rate) are depicted in Table 3 .
Every statistical model which is generated based on a previously selected data set of observations, includes information of just a portion of the universe and has an error range, which the researcher tries to minimize during the modeling process. In this sense, the false positive rate, as well as the false negative rate, are used as measures of the error range and the confiability of the model. A correct selection of a training data sets can reduce the magnitude of both measures. We took this aspect into consideration and built a training data set choosing chemicals with so much structural variability as possible. Despite of the previous precaution, it can happen that the combination of some structural paterns of a positive case, for instance, results in mathematical values wich are closer to those obtained from the combination of structural fragments in a negative observation. In such a case the model will not recognize the true class of the observation. In the present study, three active and three inactive compounds were missclasified. Here it is also important to note, that the declaration of each nonantitrypanosomal compound as "inactive" does not mean that there not exist antitrypanosomal side-effects, given it can include organic drugs for which antitrypanosomal activity has been left undetected so far. In this sense, any discriminant model can be continuously transformed and improved, taking into consideration unavailable information at the time of the model's development. This problem can affect in some degree the results of further classification. Just testing the biological activity of them it is possible to ensure the absence of antitrypanosomal effects. In this sense, we can recommend carrying out the biological assays for previously declared "inactive" compounds, for which the model give a positive classification.
Considering that a discriminant model could be accepted or rejected depending on its predictive power, it is clear to see that validation processes constitute obligated steps for the assessment of any structure-activity relationship. As Golbraikh and Tropsha emphasized, the predictive ability of a QSAR model can only be estimated using an external test set of compounds which were never used for the development of the model. 45 In this sense, it is important to secure, that the prediction algorithm is able to perform well on novel data from the same data domain. In our case, as first validation experiment, an external prediction data set was evaluated. The computation of some performance measures such as Matthews correlation coefficient, percentage of global good classification (accuracy), sensitivity, specificity, false alarm rate and negative predictive value (sensitivity of the negative category) permitted us to carry out the assessment of the model. In Table 3 are also depicted the results for this validation process. The classification's results using model 8 for active and inactive compounds in the selected test set are shown in Table 4 . A second validation experiment was also developed upon the base of a Leave-Group-Out internal cross-validation strategy. 46 In this case, groups of compounds including 10% of the training data set are left out and afterwards predicted for the model obtained with the remaining 90%. This process was repeated 10 times for each one of the 10 unique subsets selected at random and each observation predicted once (in its group of left-out observations).
The overall mean for this process (10% full leave-out cross-validation) was used as a good indication of robustness and stability of the obtained models. In Table 5 the results of classification for each 10%-group, as well as the classification for the remaining training set leaving out each one of those groups are depicted. From these results we can conclude, that also by this experiment, our model had a robust and stable behavior. No previous reports related to the application of pattern recognition techniques to the selection of antitrypanosomal compounds from a heterogeneous series of compounds were found in the literature. In this sense, the present algorithm constitutes a step forward in the search of efficient ways to discover new antitrypanosomal drugs.
With the aim to evaluate the applicability of the present TOMOCOMD metodology, four families of 2D molecular descriptors were computed with the DRAGON Software 47 and the respective models were generated. The statistical parameters are shown in Table 6 . As can be seen, in not one case the classification results are better than those obtained using model 8.
These results are a proof of the usefullness of the TOMOCOMD startegy in the study of this biological property. as an example of applicability of our approach, we selected a series of ten new synthesized heterocyclic compounds obtained in one of our research groups. [48] [49] [50] [51] As first step of this virtual screening, all structures were drawn using de drawing mode activity. 52 However, once this first assays have been performed, more selective methods are required to determine the activity of novel compounds. In the current work, the preliminary screening on epimastigotes forms was the election way to evaluate the activity of the predicted compounds, which structures are shown in Figure 4 . The results of the prediction process using model 8, as well as the anti-epimastigotes percentage for each assayed compound are summarised in Table 7 . In this case, nifurtimox was employed as reference drug. As predicted, five compounds (compounds 1s-5s) showed trypanocidal activity (%AE>70).
Compounds 2s, 3s and 5s are only active against epimatigotes at 100 µg/ml. Two compounds, 1s and 4s, showed appreciable activity at concentration of 10 µg/ml. Specifically compound 4s resulted very interesting for having inhibition percentages (%AE) higher than 80% at 100,10 and 1 µg/ml. Further research will be required to investigate the mechanism of action of these compounds and to evaluate their cytotoxicity at the assayed concentrations. The remaining five compounds which were classified as inactive for the model, showed very low inhibition percentages. For compounds 7s and 8s for instance, 0.0% and 6.9% of inhibition were determined at 100µg/ml and 0.0 % at other concentrations. According to the model, these are the compounds with a greater probability to result inactive ones.
This first virtual screening demonstrates the ability of the present TOMOCOMD approach to be used for discriminating compounds with potential antitrypanosomal activity from those without this action. These results open at the same time a door for the study of several families of heterocyclic compound, which seems to be promissory sources of antitrypanosomal drugs.
Current investigations are been developed in this direction by our research groups.
Concluding remarks
The search of effective and rational methodologies for the discovery of new drugs has turn into a first-line objective for the pharmaceutical research. In spite of some criticism, Upon the base of the current results we can conclude, that the TOMOCOMD strategy can be successfully used in the rational search of novel antitrypanosomal compounds.
Experimental Section
Computational Approach. Calculations were carried out on a PC Pentium-4 2.0 GHz. The CARDD-module implemented in the TOMOCOMD Software 13 was used to the calculation of total and local non-stochastic quadratic indices. Pauling electronegativities 53 were used as atomic weights (molecular vector's components).
Topological descriptors, molecular walk counts, BCUT descriptors and 2D autocorrelations were calculed by using the DRAGON Software. 47 The molecualr structure of each compound was drawn by using the CHEMDRAW software 54 Models with a proportion between the number of cases and variables in the equation lower than 4 were rejected. The statistical robustness and predictive power of the obtained model was assessed using an external prediction (test) set. A leave-group out (10%) cross validation procedure was also carried out for this proposes.
Parasites and culture procedure. CL strain parasites (clone CL-B5) stably transfected with the Escherichia coli β-galactosidase gene (LacZ) were used for the assays. Epimastigotes were grown at 28º C in liver infusion tryptone broth (LIT) with 10% foetal bovine serum (FBS), penicillin and streptomycin.
Antiepimastigote assay. 52 The screening assay was performed in 96-well microplates with culture that had not reached the stationary phase. Epimastigotes forms, CL strain, were seeded at concentration of 1 x 10 5 per ml in 200 µl. The plates were then incubated at 28º C for 72
hours with various concentrations of the drugs (100, 10 and 1 µg/ml), at which time 50 µl of CPRG solution was added to give a final concentration of 200 µM. The plates were incubated at 37º C for an additional 6 hrs and were then read at 595 nm. Each concentration was assayed three times. In order to avoid drawback, medium, negative and drug controls were used in each test. The anti-epimastigotes percentage (%AE) was calculated as follows:
